Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 13.40%180.17B | 13.33%167.7B | 8.62%155.67B | 10.99%637.96B | 10.49%187.79B | 11.04%158.88B | 10.12%147.98B | 12.53%143.31B | 11.83%574.79B | 13.91%169.96B |
| Operating revenue | 13.40%180.17B | 13.33%167.7B | 8.62%155.67B | 10.99%637.96B | 10.49%187.79B | 11.04%158.88B | 10.12%147.98B | 12.53%143.31B | 11.83%574.79B | 13.91%169.96B |
| Cost of revenue | 9.50%88.67B | 9.52%80.81B | 5.98%76.98B | 7.07%326.29B | 6.85%98.89B | 7.94%80.98B | 6.36%73.79B | 7.14%72.63B | 5.51%304.74B | 8.07%92.55B |
| Gross profit | 17.46%91.5B | 17.12%86.89B | 11.33%78.69B | 15.41%311.67B | 14.84%88.9B | 14.46%77.9B | 14.12%74.19B | 18.66%70.68B | 19.94%270.05B | 21.78%77.41B |
| Operating expense | 22.46%74.08B | 13.78%67.72B | 8.87%60.29B | 4.24%243.08B | 5.45%67.7B | 6.36%60.49B | 3.82%59.52B | 1.06%55.37B | 9.53%233.19B | 5.54%64.2B |
| Selling and administrative expenses | 9.30%14.56B | 6.11%14.38B | -0.10%12.39B | -1.64%55.27B | 0.47%15.99B | 1.60%13.32B | -2.82%13.55B | -6.14%12.4B | 3.80%56.19B | -1.48%15.91B |
| -Selling and marketing expense | 10.15%11.69B | 8.60%11.42B | 1.05%9.76B | -1.04%43.91B | 1.72%13.12B | 0.55%10.61B | -2.17%10.51B | -5.01%9.66B | 5.05%44.37B | 0.66%12.9B |
| -General and administrative expense | 5.97%2.88B | -2.50%2.97B | -4.16%2.63B | -3.87%11.36B | -4.88%2.86B | 5.94%2.71B | -5.03%3.04B | -9.89%2.74B | -0.63%11.82B | -9.69%3.01B |
| Other operating expenses | 26.18%59.52B | 16.04%53.34B | 11.46%47.9B | 6.10%187.81B | 7.09%51.71B | 7.78%47.17B | 5.96%45.97B | 3.35%42.97B | 11.48%177.01B | 8.08%48.29B |
| Operating profit | 0.06%17.42B | 30.66%19.17B | 20.24%18.41B | 86.13%68.59B | 60.52%21.2B | 55.62%17.41B | 91.02%14.67B | 220.63%15.31B | 200.88%36.85B | 382.61%13.21B |
| Net non-operating interest income (expenses) | -13.94%562M | -3.72%569M | 50.43%525M | 1,074.68%2.27B | 260.64%678M | 2,276.67%653M | 430.17%591M | 264.62%349M | 83.09%-233M | 175.50%188M |
| Non-operating interest income | -12.42%1.1B | -8.05%1.09B | 7.35%1.07B | 58.60%4.68B | 38.51%1.25B | 61.86%1.26B | 78.52%1.18B | 62.52%993M | 198.18%2.95B | 102.47%901M |
| Non-operating interest expense | -10.78%538M | -12.39%516M | -15.99%541M | -24.39%2.41B | -20.06%570M | -25.19%603M | -29.88%589M | -21.75%644M | 34.43%3.18B | 2.74%713M |
| Other net income (expenses) | 37,825.93%10.19B | 6,305.56%1.12B | 202.80%2.75B | -339.87%-2.25B | 61.94%468M | -102.62%-27M | -129.51%-18M | -503.61%-2.67B | 105.58%938M | 108.38%289M |
| Gain on sale of security | 56,738.89%10.2B | 3,008.33%1.12B | 214.67%2.78B | -264.04%-1.83B | 114.44%579M | -101.66%-18M | -63.27%36M | -624.18%-2.43B | 106.85%1.12B | 108.99%270M |
| Other non-operating income (expenses) | 0.00%-9M | 96.30%-2M | 86.69%-33M | -137.85%-421M | -684.21%-111M | 82.35%-9M | -45.95%-54M | -129.63%-248M | 67.22%-177M | 104.24%19M |
| Income before tax | 56.18%28.17B | 36.81%20.86B | 66.98%21.68B | 82.69%68.61B | 63.30%22.35B | 47.98%18.04B | 101.57%15.25B | 215.20%12.98B | 732.70%37.56B | 1,522.66%13.69B |
| Income tax | 155.36%6.91B | 51.56%2.68B | 84.56%4.55B | 30.13%9.27B | -24.07%2.33B | 17.35%2.71B | 119.78%1.77B | 160.23%2.47B | 321.32%7.12B | 349.55%3.06B |
| Earnings from equity interest net of tax | -2,333.33%-73M | -314.29%-15M | 101.18%1M | -741.67%-101M | -20M | 25.00%-3M | 177.78%7M | -8,600.00%-85M | -300.00%-12M | 0 |
| Net income | 38.22%21.19B | 34.70%18.16B | 64.19%17.13B | 94.73%59.25B | 88.29%20B | 55.16%15.33B | 99.78%13.49B | 228.85%10.43B | 1,217.74%30.43B | 3,721.58%10.62B |
| Net income continuous operations | 38.22%21.19B | 34.70%18.16B | 64.19%17.13B | 94.73%59.25B | 88.29%20B | 55.16%15.33B | 99.78%13.49B | 228.85%10.43B | 1,217.74%30.43B | 3,721.58%10.62B |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 38.22%21.19B | 34.70%18.16B | 64.19%17.13B | 94.73%59.25B | 88.29%20B | 55.16%15.33B | 99.78%13.49B | 228.85%10.43B | 1,217.74%30.43B | 3,721.58%10.62B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 38.22%21.19B | 34.70%18.16B | 64.19%17.13B | 94.73%59.25B | 88.29%20B | 55.16%15.33B | 99.78%13.49B | 228.85%10.43B | 1,217.74%30.43B | 3,721.58%10.62B |
| Diluted earnings per share | 35.62%0.1725 | 32.56%0.149 | 62.00%0.1411 | 91.86%0.493 | 84.47%0.1655 | 52.08%0.1272 | 95.45%0.1124 | 222.58%0.0871 | 1,192.61%0.257 | 3,333.52%0.0897 |
| Basic earnings per share | 36.36%0.1699 | 33.33%0.1463 | 62.24%0.1385 | 90.69%0.4817 | 86.00%0.162 | 52.13%0.1246 | 93.85%0.1098 | 216.12%0.0854 | 1,174.09%0.2526 | 3,233.52%0.0871 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.